Basaranoglu Metin, Canbakan Billur, Yildiz Kemal, Ceylan Bahadir, Baysal Birol, Uysal Omer, Senturk Hakan
Division of Gastroenterology, Department of Internal Medicine, Medical School, BezmiAlem Vakif University, 34000, Istanbul, Turkey.
Wien Klin Wochenschr. 2016 Oct;128(19-20):691-694. doi: 10.1007/s00508-015-0744-4. Epub 2015 Apr 14.
Fatty liver is a common disease in developed countries. We investigated the frequency of operation in patients with fatty liver and the frequency of cancer in their first-degree relatives.
In this study, we evaluated 105 patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD), 121 patients with hepatitis C (61 patients with fatty liver and 60 patients without fatty liver), 50 patients with inflammatory bowel disease (IBD), and 109 patients with dyspepsia as a control group.
There was no difference for sex, mean age, and marital status among the groups, except that patients with IBD were younger than others (p < 0.001). The frequency of cancer in family was as follows: 18 % in IBD, 9 % in dyspepsia, 28 % in hepatitis C with hepatic steatosis, 21.5 % in hepatitis C without steatosis, and 27 % in NAFLD (p = 0.006). Then, we divided the study group into two groups-group 1: IBD + dyspepsia + hepatitis C without hepatic steatosis, and group 2: hepatitis C with hepatic steatosis + NAFLD-and performed the same analysis. We found that the frequency of cancer in family was 16 % in group 1 (the patients without fatty liver) vs. 24.4 % in group 2 (those with fatty liver; p = 0.037). We also investigated the rate of operation in patients. The results were as follows: 33 % in group 1 vs. 43 % in group 2 (p = 0.043).
Independently of the underlying chronic diseases, occurrence of fat in the liver increased the frequency of operation in patients with fatty liver and the rate of cancer in their first-degree relatives. Understanding the underlying causes of fatty liver forms might decrease the cancer frequency in the population and number of operation in patients with fatty liver.
脂肪肝在发达国家是一种常见疾病。我们调查了脂肪肝患者的手术频率及其一级亲属的癌症发病率。
在本研究中,我们评估了105例经活检证实的非酒精性脂肪性肝病(NAFLD)患者、121例丙型肝炎患者(61例伴有脂肪肝,60例不伴有脂肪肝)、50例炎症性肠病(IBD)患者以及109例消化不良患者作为对照组。
各研究组之间在性别、平均年龄和婚姻状况方面无差异,但IBD患者比其他患者年龄更小(p < 0.001)。家族中癌症发病率如下:IBD组为18%,消化不良组为9%,丙型肝炎合并肝脂肪变性组为28%,丙型肝炎无脂肪变性组为21.5%,NAFLD组为27%(p = 0.006)。然后,我们将研究组分为两组——第1组:IBD + 消化不良 + 丙型肝炎无肝脂肪变性组,第2组:丙型肝炎合并肝脂肪变性 + NAFLD组——并进行相同分析。我们发现,第1组(无脂肪肝患者)家族中癌症发病率为16%,而第2组(有脂肪肝患者)为24.4%(p = 0.037)。我们还调查了患者的手术率。结果如下:第1组为33%,第2组为43%(p = 0.043)。
独立于潜在的慢性疾病,肝脏脂肪的出现增加了脂肪肝患者的手术频率及其一级亲属的癌症发病率。了解脂肪肝形成的潜在原因可能会降低人群中的癌症发病率以及脂肪肝患者的手术数量。